Trial Profile
Phase I Study of Plitidepsin (Aplidin) in Combination With Bortezomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Plitidepsin (Primary) ; Bortezomib; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions
- Sponsors PharmaMar
- 03 Jul 2018 Status changed from active, no longer recruiting to completed.
- 20 Jan 2017 Planned End Date changed from 1 Mar 2016 to 1 Dec 2018.
- 20 Jan 2017 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2018.